The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial

Contemporary Clinical Trials - Netherlands
doi 10.1016/j.cct.2014.01.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Comparative Study Between Sacral Neuromodulation and Intravesical Botulinum Toxin Injection for Patients With Refractory Overactive Bladder

Arab Journal of Urology
Urology
2020English

Mp77-14 Sacral Neuromodulation for Refractory Overactive Bladder After Prior Intravesical Onabotulinumtoxina Treatment.

Journal of Urology
Urology
2016English

Neuromodulation for Refractory Overactive Bladder in Men

Trends in Urology & Men's Health
2018English

The Second-Line Management of Idiopathic Overactive Bladder: What Is the Place of Sacral Neuromodulation and Botulinum Toxin-A in Contemporary Practice?

BJU International
Urology
2009English

Sacral Neuromodulation for Treatment of Overactive Bladder: A Review

Revista de Medicina
2018English

PMD68 Cost-Effectiveness of Sacral Neuromodulation in the Treatment of Idiopathic Wet Refractory Overactive Bladder in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Botulinum Toxin a for the Treatment of Overactive Bladder

Toxins
MutagenesisToxicologyHealth
2016English

Botulinum Toxin Therapy for Nonneurogenic Overactive Bladder: First Experience

Acta medica Lituanica
2011English

Botulinum Toxin-A for the Treatment of Overactive Bladder: UK Contributions

Journal of Clinical Urology
SurgeryUrology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy